KRT88P and autoimmune hepatitis: These findings support broader HBV screening strategies in AIH, including tests for anti-HBc IgG, HBsAg, anti-HBs, and, where relevant, HBV-DNA-even in the absence of immunosuppressive regimens known for high reactivation risk [10-12].